Statin use and colorectal adenoma risk: Results from the Adenoma Prevention with Celecoxib (APC) trial

被引：0
|
作者：
Bertagnolli, Monica Marie
Hsu, Meier
Hawk, Ernest T.
Eagle, Craig J.
Zauber, Ann G.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-LB-173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-173
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Statin Use and Colorectal Adenoma Risk: Results from the Adenoma Prevention with Celecoxib Trial
    Bertagnolli, Monica M.
    Hsu, Meier
    Hawk, Ernest T.
    Eagle, Craig J.
    Zauber, Ann G.
    CANCER PREVENTION RESEARCH, 2010, 3 (05) : 588 - 596
  • [2] Aberrant crypt foci (ACF) are not surrogate biomarkers of sporadic adenoma prevention with celecoxib: Results from the Adenoma Prevention with Celecoxib (APC) trial
    Cho, Nancy L.
    Redston, Mark
    Zauber, Ann G.
    Carothers, Adelaide M.
    Hornick, Jason L.
    Wilton, Andrew
    Sontag, Stephen
    Nishioka, Norman
    Giardiello, Frances
    Saltzman, John R.
    Gostout, Chris
    Eagle, Craig J.
    Hawk, Ernest T.
    Bertagnolli, Monica M.
    CANCER RESEARCH, 2008, 68 (09)
  • [3] Celecoxib reduces formation of sporadic adenomas: results from the adenoma prevention with celecoxib (APC) trial
    Macrae, F.
    Jones, I. T.
    Pizzey, C.
    Bertagnolli, M.
    Hawk, E.
    Eagle, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A264 - A264
  • [4] Risk of Colorectal Adenoma Recurrence Due to Red Blood Cell Folate Level in the Post Folate Fortification Era: Results From the Adenoma Prevention With Celecoxib (APC) Trial
    Chou, Joanne F.
    Eslick, Guy D.
    Vitolins, Mara Z.
    Tooze, Janet A.
    Bacher, Jason
    Giovannucci, Edward
    Bertagnolli, Monica M.
    Zauber, Ann G.
    GASTROENTEROLOGY, 2010, 138 (05) : S348 - S348
  • [5] Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
    Solomon, SD
    McMurray, JJV
    Pfeffer, MA
    Wittes, J
    Fowler, R
    Finn, P
    Anderson, WF
    Zauber, A
    Hawk, E
    Bertagnolli, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11): : 1071 - 1080
  • [6] The Adenoma Prevention with Celecoxib (APC) trial: Five-year efficacy and safety results
    Bertagnolli, Monica M.
    Zauber, Ann G.
    Hawk, Ernest T.
    CANCER RESEARCH, 2008, 68 (09)
  • [7] Regular Statin use and colorectal adenoma risk
    Fiske, William H.
    Smalley, Walter E.
    Shrubsole, Martha
    Murff, Harvey
    Shyr, Yu
    Ness, Reid M.
    Zheng, Wei
    GASTROENTEROLOGY, 2007, 132 (04) : A441 - A441
  • [8] Insights From the Adenoma Prevention With Celecoxib Trial and Risk for Cardiovascular Adverse Events
    Kraus, Sarah
    Arber, Nadir
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (01) : 1 - 3
  • [9] Statin use and the risk of colorectal adenoma: A meta-analysis
    Jung, Yoon Suk
    Park, Chan Hyuk
    Eun, Chang Soo
    Park, Dong Il
    Han, Dong Soo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (11) : 1823 - 1830
  • [10] Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
    Cho, Nancy L.
    Redston, Mark
    Zauber, Ann G.
    Carothers, Adelaide M.
    Hornick, Jason
    Wilton, Andrew
    Sontag, Stephen
    Nishioka, Norman
    Giardiello, Francis M.
    Saltzman, John R.
    Gostout, Chris
    Eagle, Craig J.
    Hawk, Ernest T.
    Bertagnolli, Monica M.
    CANCER PREVENTION RESEARCH, 2008, 1 (01) : 21 - 31
12345